PUBLISHER: The Business Research Company | PRODUCT CODE: 1760564
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760564
In vitro diagnostic (IVD) packaging involves specialized materials and containers designed to store, protect, and transport IVD devices. These devices are used to perform tests on biological samples, such as blood or tissue, for diagnosing diseases or monitoring health conditions. Proper packaging is essential to maintain the integrity and reliability of these devices throughout their lifecycle, safeguarding them from contamination, damage, and environmental influences.
In vitro diagnostic packaging consists of primary, secondary, and tertiary packaging types. Primary packaging refers to the direct container or material that encloses and protects the diagnostic product, ensuring its safety, integrity, and functionality before use. Examples of primary packaging include bottles, vials, tubes, petri dishes, closures, and others, made from materials such as plastic, glass, metal, and composites. These products are utilized in fields such as biochemistry, microbiology, immunology, and molecular diagnostics by end users such as hospitals, laboratories, academic institutions, and others.
The in vitro diagnostic packaging market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostic packaging market statistics, including in vitro diagnostic packaging industry global market size, regional shares, competitors with an in vitro diagnostic packaging market share, detailed in vitro diagnostic packaging market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostic packaging industry. This in vitro diagnostic packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The in vitro diagnostic packaging market size has grown strongly in recent years. It will grow from $9.37 billion in 2024 to $10.12 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historical period can be attributed to factors such as the increasing demand for early disease detection, a rise in the prevalence of chronic diseases, higher healthcare spending, the expansion of diagnostic laboratories, and the growth of point-of-care testing.
The in vitro diagnostic packaging market size is expected to see strong growth in the next few years. It will grow to $13.66 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period is expected to be driven by the rising demand for personalized medicine, an expanding elderly population, advancements in diagnostic technologies, greater adoption of home testing kits, and stricter regulatory standards for packaging safety. Key trends anticipated during the forecast period include the use of sustainable and recyclable packaging materials, the adoption of smart packaging technologies, the miniaturization of diagnostic kits, a rise in outsourcing packaging services, and a growing demand for tamper-evident and sterile packaging solutions.
The increasing prevalence of chronic diseases and infections is expected to drive the growth of the in vitro diagnostic (IVD) packaging market. Chronic diseases and infections are long-term health conditions or diseases caused by persistent pathogens, which often lead to extended medical complications. The rise in these health issues is linked to greater exposure to pathogens, with lifestyle factors such as poor diet and lack of physical activity playing a key role. IVD packaging supports the fight against these diseases by ensuring safe, reliable, and efficient delivery of diagnostic tests, enabling early detection and timely treatment, which ultimately improves patient outcomes and healthcare efficiency. For example, in March 2025, data from the UK Health Security Agency showed a significant increase in measles cases in England, with 368 reported cases in 2023 compared to only 53 in 2022, highlighting the growing need for diagnostics. This surge in chronic and infectious diseases is thus driving the growth of the IVD packaging market.
Companies in the IVD packaging market are also focused on developing sustainable packaging solutions to reduce environmental impact while maintaining product safety. Sustainable IVD packaging uses eco-friendly materials and practices to package diagnostic products, aiming to lower environmental footprints. For instance, in March 2025, Oxford Gene Technology introduced a new sustainable packaging solution for its CytoCell product line. This packaging utilizes biodegradable and recyclable materials, reflecting the broader industry trend toward eco-friendly practices. The redesign not only supports sustainability but also improves efficiency in laboratories by providing streamlined digital documentation. This move highlights the company's commitment to reducing waste and improving operational efficiency in the clinical and diagnostic sectors.
In March 2022, TriMas Corporation, a U.S.-based manufacturer of engineered products, acquired Intertech Plastics for $64.1 million. This acquisition aims to expand TriMas' portfolio of specialized plastic products and strengthen its position in providing innovative packaging solutions for the healthcare and consumer sectors. Intertech Plastics is known for its work in providing in-vitro diagnostic packaging.
Major players in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc., Corning Incorporated, Intertek Group plc, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd, Narang Medical Limited, Thousand Peak Glass Bottle CO.LTD.
North America was the largest region in the in vitro diagnostic packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in vitro diagnostic packaging report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the in vitro diagnostic packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in vitro diagnostic packaging market consists of sales of sterile containers, tamper-evident seals, temperature-controlled packaging, and moisture-resistant materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In Vitro Diagnostic Packaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in vitro diagnostic packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for in vitro diagnostic packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostic packaging market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.